Notification of Policy Revisions Effective May 26, 2020 Posted March 24, 2020
Medical Policy | Revision |
Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders | Regulatory section updated with FDA unit limits. Policy Guidelines updated with support of unit limits. Note added limiting units in When covered section. References added. Policy noticed 3/24/20 for effective date 5/26/20. |
Treatment For Opioid Use Disorder in Opioid Treatment Programs (OTPs) | Notification of new policy. Notification given 3/24/2020 for effective date 5/26/2020. |